Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (CA2909335) FENFLURAMINE FOR USE IN THE TREATMENT OF DRAVET SYNDROME

Office : Canada
Application Number: 2909335 Application Date:
Publication Number: 2909335 Publication Date: 06.11.2014
Publication Kind : A1
Prior PCT appl.: Application Number:PCTEP2014058954 ; Publication Number: Click to see the data
IPC:
A61K 31/137
A61K 45/06
A61P 25/08
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
13
Amines, e.g. amantadine
135
having aromatic rings, e.g. methadone
137
Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45
Medicinal preparations containing active ingredients not provided for in groups A61K31/-A61K41/132
06
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25
Drugs for disorders of the nervous system
08
Antiepileptics; Anticonvulsants
CPC:
A61K 31/137
A61K 31/135
A61K 31/19
A61K 31/36
A61K 31/5513
A61K 45/06
Applicants: KATHOLIEKE UNIVERSITEIT LEUVEN
UNIVERSITY HOSPITAL ANTWERP
Inventors:
Priority Data: 13/887,014 03.05.2013 US
Title: (EN) FENFLURAMINE FOR USE IN THE TREATMENT OF DRAVET SYNDROME
(FR) FENFLURAMINE DESTINEE A ETRE UTILISEE POUR LE TRAITEMENT DU SYNDROME DE DRAVET
Abstract:
(EN) An effective dose of fenfluramine or its pharmaceutically acceptable salt for use in a method of treating and/or preventing Dravet Syndrome in a patient such as a patient previously diagnosed with Dravet Syndrome.


Also published as:
EP2991637AU2014261329BR112015027282DK2991637ES2666657EP3329909
PT2991637WO/2014/177676